APA aipamena

Powles, T., Necchi, A., Rosen, G., Hariharan, S., & Apolo, A. B. (2017). Anti-programmed cell death-1/ligand-1 (PD-1/PD-L1) antibodies for the treatment of urothelial carcinoma: State-of-the-art and future development. Clin Genitourin Cancer.

Chicago Style aipamena

Powles, Thomas, Andrea Necchi, Galit Rosen, Subramanian Hariharan, and Andrea B. Apolo. "Anti-programmed Cell Death-1/ligand-1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State-of-the-art and Future Development." Clin Genitourin Cancer 2017.

MLA aipamena

Powles, Thomas, et al. "Anti-programmed Cell Death-1/ligand-1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State-of-the-art and Future Development." Clin Genitourin Cancer 2017.